KUALA LUMPUR: Pharmaniaga Bhd
today announced that Messrs. PricewaterhouseCoopers PLT (PwC) has resigned as its external auditor, following a written notice served to the group on Sept 20.
In a filing with Bursa Malaysia, the pharmaceutical group said PwC's resignation is on a voluntary basis. The Board also informs that the company is not aware of any issues that need to be brought to the shareholders' attention.
“The Board noted that PwC has served as the external auditors for the company for the past 19 years, and the board agrees that the resignation and the subsequent appointment of new external auditors would allow a fresh perspective for the board and the company. The change is also intended to align with the groupwide approach to streamline its external auditors,” it said.
“With the audit committee’s recommendation, the board has approved the appointment of Messrs. Ernst & Young (EY) after assessing their independence, capabilities, audit team and proposed audit fees for the financial year ending Dec 31, 2024, in place of PwC subject to the company receiving the written consent to act as external auditors of the company from EY pursuant to Section 264(5) of the Companies Act 2016,” Pharmaniaga said.
